Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Presenter: Raj Makkar

October 28, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

JenaValve

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

JenaValve Following Previous Ross Procedure

Presenter: Daniel Zumerkorn Hassan

June 06, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Caitlin E. Cox

November 15, 2023

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

Presentation TCT 2023

TCT 288: Implantation Depth and Need for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the JenaValve System in Patients with Severe Aortic Regurgitation

Presenter: Matti Adam

October 25, 2023

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

L.A. McKeown

September 26, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

Presentation TCT 2022

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

Presenter: Alexander R. Tamm

September 18, 2022

The Dedicated JenaValve TAVR System for AI: Early EU and US Experiences

Presentation TCT 2022

The Dedicated JenaValve TAVR System for AI: Early EU Experience

Presenter: Alexander Tamm

September 18, 2022

Advertisement

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Top Structural Heart News of 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Experience With JenaValve – Technology, Case Examples, and Clinical Trials

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

JenaValve

JenaValve Following Previous Ross Procedure

Top Structural Heart News of 2023

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

TCT 288: Implantation Depth and Need for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the JenaValve System in Patients with Severe Aortic Regurgitation

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

What’s Going to Be Hot at TCT 2023

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

The Dedicated JenaValve TAVR System for AI: Early EU Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content